Posts by: Leonor Mateus Ferreira

Leonor Mateus Ferreira

Leonor Mateus Ferreira is an emerging, young journalist, with a Batchelor's degree in Communication and post-graduate degree in Multiplatform Journalism. She is particularly interested in politics and current affairs, and is currently studying for a masters degree in economics and public policies.

February 3, 2015November 9, 2015

Serendex and CMC Biologics Sign Partnership on Lung Drug

COPD, News

Serendex Pharmaceuticals has established an exclusive agreement with CMC Biologics, Inc. focused on the development of a treatment for Diffuse Alveolar Hemorrhage, an acute bleeding in the lungs. The therapy, called Factor VIIa, ... Read more

January 28, 2015November 5, 2015

PF Foundation Adds 12 New Sites to PFF Care Center Network

Idiopathic Pulmonary Fibrosis, News

The Pulmonary Fibrosis Foundation (PFF) has added 12 new sites to its PFF Care Center Network, which was launched in 2013 to accredit leading medical centers particularly dedicated to the diagnosis and ... Read more

January 27, 2015November 5, 2015

Eleven New PH Care Centers Accredited by the Pulmonary Hypertension Association

News, Pulmonary Hypertension

Eleven new health care centers have received accreditation from the Pulmonary Hypertension Association (PHA) to become recognized Pulmonary Hypertension Care Centers (PHCC). With these additions, there are now 17 PHCCs in the ... Read more

January 23, 2015January 23, 2015

Ventana Submits Lung Cancer Diagnostic Test to FDA Premarket Approval

Lung Cancer, News

Ventana Medical Systems, Inc. has filed a submission with the U.S. Food and Drug Administration (FDA) requesting the premarket approval (PMA) of a diagnostic test to identify anapestic lymphoma receptor tyrosine kinase (ALK) positive lung ... Read more

January 23, 2015January 23, 2015

Gensignia Lung Cancer Diagnosis Method Recognized by ASCO

News

Molecular diagnostics company, Gensignia Life Sciences, Inc., has been recognized by the American Society of Clinical Oncology (ASCO) for its contributions in improving low-dose CT lung cancer screening efficacy. The recognition was granted in the Clinical Cancer Advances 2015: ... Read more

January 21, 2015January 21, 2015

Three New Members Join Lung Cancer Alliance Board of Directors

News

The Lung Cancer Alliance has nominated three new members to join its Board of Directors and help the organization with its mission of accelerating research on lung cancer, as announced ... Read more

January 16, 2015November 5, 2015

Arena to Initiate Dosing on Phase 2 PAH Therapy Study

News, Pulmonary Hypertension

Arena Pharmaceuticals, Inc. has announced that it will initiate dosing of the first patients in its phase 2 clinical trial for the evaluation of a potential therapy for pulmonary arterial hypertension (PAH), called ralinepag. ... Read more

January 14, 2015January 14, 2015

Lung Therapeutics’ Empyema Drug Receives European Orphan Medicinal Product Status

News, Pneumonia

Pharmaceutical company Lung Therapeutics, Inc. has received the orphan medicinal product designation from the European Commission (EC) for its lead drug candidate LTI-01 for the treatment of empyema, a complication related to pneumonia. The status was ... Read more

January 9, 2015November 5, 2015

Pacific Therapeutics Announces 2015 Strategy Focused on IPF

Idiopathic Pulmonary Fibrosis, News

Clinical stage specialty pharmaceutical company Pacific Therapeutics has announced its new strategy for 2015, as well as corporate updates to its shareholders, expressing its continued focus on the treatment of ... Read more

January 8, 2015November 5, 2015

Protalix Sets New Strategy with Focus on Cystic Fibrosis Treatment

Cystic Fibrosis, News

Protalix BioTherapeutics, Inc. has established a new strategic approach with the purpose of accelerating its growth while continuing to focus on prioritizing both its new pipeline drug candidates as well as currently available therapies. ... Read more